A Clinical Trial to Assess PVX7 Immunotherapy Regimens in Advanced Cervical Cancer Patients (NCT06315257)
A Randomized, Open-label Clinical Trial to Assess the Safety, Feasibility and Immunogenicity of Adjuvant PVX7 Immunotherapy Regimens in Advanced Cervical Cancer Patients
π©Ί Plain-English Summary (8th-Grade Level)
A Feasibility Trial of PVX7 vaccine in advanced cervical cancer patients who have completed primary definitive therapy.
Who can join: Review the eligibility criteria below.
Location: The University of Alabama at Birmingham β Birmingham, Alabama
Age range: 18 Years
π§ͺ Interventions in This Study
π "Do I Qualify?" β 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria β
π All Participating Trial Locations (2 Sites)
- The University of Alabama at Birmingham β Birmingham, Alabama
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins β Baltimore, Maryland
π Contact the Study Coordinator
Phone: (410) 614-1361
Email: HopkinsGynTrials@jhmi.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
π° Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA Β§ 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Cervical Cancer
- SUCCESS - Feasibility of HPV Testing and Treatment of Pre-cancerous Cervical Cancer Lesions (HPV Study) β Ouagadougou,
- Dostarlimab and Cobolimab in Advanced Cervical Cancer β Boston, Massachusetts
- International Validation Study of Sentinel Node Biopsy in Early Cervical Cancer β LiΓ¨ge,
- Prospective Evaluation of Self-Testing to Increase Screening (PRESTIS) Asian/Asian American Women Supplement β Houston, Texas
- Sexual Health Empowerment for Women's Health β Kansas City, Missouri
- Evaluating Innovative Technologies and Approaches to Addressing Cervical Cancer in Gaza and Maputo Cidade Provinces in Mozambique β Houston, Texas
Explore by condition: All Cervical Cancer clinical trials
π‘ How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.